Showing results (71-80 of 241) with videos related to
Sort By:
Pageof 25
The Journal of Physiology|November 7, 2012
Preserved fertility despite erectile dysfunction in mice lacking the nitric oxide receptorDieter Groneberg, Barbara Lies, Peter König, et al.Proceedings of the National Academy of Sciences of the United States of America|February 20, 2004
Reduced inflammatory hyperalgesia with preservation of acute thermal nociception in mice lacking cGMP-dependent protein kinase IIrmgard Tegeder, Domenico Del Turco, Achim Schmidtko, et al.Neuropharmacology|August 22, 2017
K<sub>Ca</sub>3.1 channels modulate the processing of noxious chemical stimuli in miceRuirui Lu, Cathrin Flauaus, Lea Kennel, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 17, 2008
Plasma concentrations of matrix metalloproteinase-2, tissue inhibitor of metalloproteinase-1 and osteopontin reflect severity of heart failure in DOCA-salt hypertensive ratFrank Kramer, Peter Sandner, Martina Klein, et al.Biochemical Pharmacology|February 13, 2019
A novel soluble guanylyl cyclase activator, BR 11257, acts as a non-stabilising partial agonist of sGCChristin Elgert, Anne Rühle, Peter Sandner, et al.Journal of Pharmaceutical and Biomedical Analysis|February 8, 2020
Thermal shift assay: Strengths and weaknesses of the method to investigate the ligand-induced thermostabilization of soluble guanylyl cyclaseChristin Elgert, Anne Rühle, Peter Sandner, et al.Molecular & Cellular Proteomics : MCP|August 30, 2008
Toponomics analysis of functional interactions of the ubiquitin ligase PAM (Protein Associated with Myc) during spinal nociceptive processingSandra Pierre, Christian Maeurer, Ovidiu Coste, et al.Annals of the Rheumatic Diseases|February 26, 2014
Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signallingChristian Beyer, Christoph Zenzmaier, Katrin Palumbo-Zerr, et al.Pain|April 20, 2005
Essential role of the synaptic vesicle protein synapsin II in formalin-induced hyperalgesia and glutamate release in the spinal cordAchim Schmidtko, Domenico Del Turco, Ovidiu Coste, et al.BJU International|September 8, 2006
Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptomsHanna Tinel, Beatrix Stelte-Ludwig, Joachim Hütter, et al.Pageof 25